Effectiveness and Safety of Dabigatran and Warfarin in Real‐World US Patients With Non‐Valvular Atrial Fibrillation: A Retrospective Cohort Study

BACKGROUND: The recent availability of dabigatran, a novel oral anticoagulant, provided a new treatment option for stroke prevention in atrial fibrillation beyond warfarin, the main therapy for years. Little is known about their real‐world comparative effectiveness and safety, even less among patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Lauffenburger, Julie C., Farley, Joel F., Gehi, Anil K., Rhoney, Denise H., Brookhart, M. Alan, Fang, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579955/
https://www.ncbi.nlm.nih.gov/pubmed/25862791
http://dx.doi.org/10.1161/JAHA.115.001798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579955/
https://www.ncbi.nlm.nih.gov/pubmed/25862791
http://dx.doi.org/10.1161/JAHA.115.001798

Ejemplares similares